Technology

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

Published

7 months ago

June 4, 2024

The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX’s Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 minutes

WESTBROOK, Maine, June 4, 2024 /CNW/ — IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go workflow of the Catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes. The Catalyst Pancreatic Lipase Test will be available in the U.S. and Canada this September, with a global rollout to the over 70,000 Catalyst installed base planned to begin in the fourth quarter of 2024.

Pancreatitis is a common disease among cats and dogs, and while treatable, it can prove fatal if not caught early. Diagnosing pancreatitis can be difficult due to its nonspecific symptoms and subtle clinical signs, including vomiting and weight loss, which are among the 10 most frequently recorded clinical signs in primary care clinics.1 Now, with the Catalyst Pancreatic Lipase Test, veterinarians can receive quantitative results in under 10 minutes. By delivering quantitative diagnostic insights during the patient visit, the new test empowers veterinarians to confidently confirm or rule out pancreatitis and immediately begin treatment, saving crucial time and improving patient outcomes.

“The Catalyst Pancreatic Lipase Test marks the tenth menu addition launched for the Catalyst platform since 2012, reinforcing our commitment to extend the clinical value and diagnostic capabilities of our technologies,” said Jay Mazelsky, President and Chief Executive Officer of IDEXX. “We are pleased to deliver a highly requested test, which will streamline the diagnostic workflow and equip veterinarians with the necessary clinical insights for prompt action.”

The Catalyst Pancreatic Lipase Test, coupled with VetConnect® PLUS software, provides a critical solution for the long-term management of pancreatitis patients due to the chronic nature of the disease. VetConnect PLUS allows for seamless integration of historical data and test results, enabling efficient patient progress evaluation and treatment response.

“The Catalyst Pancreatic Lipase Test is the first test to use dry chemistry slide technology that specifically measures pancreatic lipase and correlates with the IDEXX Reference Laboratories Spec cPL® and Spec fPL® tests* to provide the most accurate, quantitative results patient-side for dogs and cats,” said Jörg M. Steiner, Dr.med.vet., PhD, DACVIM-SA, DECVIM-CA, AGAF, Texas A&M University.†

New Catalyst SmartQC Control
In the fourth quarter of 2024, the Catalyst platform will be further enhanced with the launch of the Catalyst® SmartQC® Control, a load-and-go quality control testing system that is 90% faster than current methods.2 The Catalyst SmartQC Control offers an intuitive workflow that takes less than 15 minutes, ensuring quality control is run consistently without compromising staff productivity. These enhancements will be delivered through IDEXX SmartService™ Solutions, a cloud-based software that supports in-house instruments and powers seamless upgrades for new tests and features.

Please visit idexx.com for more information on the Catalyst Pancreatic Lipase Test and Catalyst SmartQC Control.

About IDEXX
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help ensure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500® Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit: www.idexx.com.

Note Regarding Forward-Looking Statements
This news release contains or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “expects,” “may,” “anticipates,” “intends,” “would,” “will,” “plans,” “believes,” “estimates,” “should,” “project,” and similar words and expressions. These forward-looking statements are intended to provide our current expectations or forecasts of future events; are based on current estimates, projections, beliefs, and assumptions; and are not guarantees of future performance. Actual events or results may differ materially from those described in the forward-looking statements. These statements are subject to risks, uncertainties, assumptions, and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by IDEXX pursuant to United States securities laws contain discussions of some of these risks and uncertainties. IDEXX assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are advised to review IDEXX’s filings with the United States Securities and Exchange Commission (which are available from the SEC’s EDGAR database at sec.gov and via IDEXX’s website at idexx.com).

1Robinson NJ, Dean RS, Cobb M, Brennan ML. Investigating common clinical presentations in first opinion small animal consultations using direct observation. Vet Rec. 2015;176(18):463. doi:10.1136/vr.102751
*The Spec cPL Test for dogs and the Spec fPL Test for cats measure the level of pancreas-specific lipase in the blood: www.idexx.com/en/veterinary/reference-laboratories/pancreatic-health.
†Dr. Steiner has received compensation from time to time for consulting services he has provided to IDEXX.
2Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA.

View original content to download multimedia:https://www.prnewswire.com/news-releases/idexx-expands-test-menu-for-the-catalyst-platform-to-support-veterinarians-globally-in-diagnosing-pancreatitis-302162411.html

SOURCE IDEXX Laboratories, Inc.

Technology

My China Story: Technology Brings the World Together for a Chinese New Year

Published

41 minutes ago

December 24, 2024

BEIJING, Dec. 24, 2024 /PRNewswire/ — As the Spring Festival approaches, many are preparing for their holiday travels abroad. While the excitement of spontaneous trips is undeniable, one of the biggest hurdles travelers face is language barriers. However, iFlytek‘s innovative translation device promises to make communication effortless, helping you navigate any language challenges with ease.

Known for its sleek and compact design, iFlytek’s smart translation gadget offers an elegant black, business-style exterior, a moderate size, and a lightweight build. It’s the ideal travel companion, fitting easily into your pocket without weighing you down. Whether you’re heading to a city getaway or a remote adventure, this device ensures that language is never an obstacle.

The device boasts impressive capabilities, supporting translations in 84 languages online and 16 languages offline. Whether you’re traveling to Japan, South Korea, France, Germany, or the Middle East, this device handles it all. Even in remote locations—such as secluded mountain temples or isolated islands—the offline translation feature ensures you won’t be left speechless. The device also offers specialized vocabulary for specific fields, making translations more precise and professional.

With its intuitive interface, the gadget is easy to use—just a tap, and you’re ready to communicate. This makes it a perfect tool for travelers who want to ensure a smooth and enjoyable experience while abroad.

But what lies behind this innovative device? How did it come to life? To learn more about its development and functionality, we are following a Russian journalist as he visits iFlytek’s headquarters for an exclusive look at this remarkable “gadget” and uncover the story behind its creation.

Stay tuned as we explore the technology that’s revolutionizing the way we connect across cultures.

https://youtu.be/QkdFG0LvH70

View original content to download multimedia:https://www.prnewswire.com/news-releases/my-china-story-technology-brings-the-world-together-for-a-chinese-new-year-302338865.html

SOURCE “My China Story” International Short Video Competition Organizing Committee

Technology

Cutting-edge automotive software in India: Dedicated business unit of digital transformation specialist Embitel now operates as CARIAD India

Published

2 hours ago

December 24, 2024

400-person-strong team has been an established partner on numerous technology projects for CARIAD, the automotive software company of the Volkswagen Group.Embitel Managing Director, Sharad Bairathi: “CARIAD’s internationally renowned brand name will be a major advantage in the highly competitive Indian technology sector.”CARIAD Chief Launch Officer, Thomas Günther: “Working together under the CARIAD brand strengthens our joint commitment to delivering cutting-edge automotive software solutions.”

BENGALURU, India, Dec. 24, 2024 /PRNewswire/ — The CARIAD Business Unit of Bengaluru-based digital transformation specialist Embitel now operates as CARIAD India. The 400-person-strong team has been an established partner on numerous technology projects for CARIAD, the automotive software company of the Volkswagen Group.

Since 2020, Embitel’s CARIAD Business Unit has worked successfully with CARIAD on many technology projects, primarily in the areas of platform software, Scalable Vehicle Compute Platform, high-speed communication technologies, ADAS/AD, power systems, energy and charging, and body electronics. To further strengthen this partnership, Embitel’s CARIAD Business Unit now officially operates as CARIAD India under a licensing agreement with Germany-based CARIAD SE.

Sharad Bairathi, Managing Director of Embitel, commented: “The rebranding to CARIAD India marks a significant milestone. It shows everyone how close our links with CARIAD are. The internationally renowned brand name will be a major advantage in the highly competitive Indian technology sector.”

CARIAD’s Chief Launch Officer, Thomas Günther, added: “We are welcoming our colleagues in India even closer to the team. India’s technology landscape pulsates with innovation and working together under the CARIAD brand now strengthens our joint commitment to delivering cutting-edge automotive software solutions.”

CARIAD India has grown continuously and now has close to 400 employees. It started with a small team delivering base services for the Driver Reflection Module, which is an integral part of the Volkswagen Group’s advanced driver assistance systems. This team later expanded to develop software for a microcontroller and the Scalable Vehicle Compute Platform (SVCP), a flexible system that supports various automotive functions, including communication interfaces and power management for electric cars.

The ADAS/AD team, established in 2022, works on behaviour software, sensors, map localization, driving, and safety projects. Equipped with advanced systems, the lab in Bengaluru is a key partner for CARIAD in Germany and internationally.

CARIAD India has also established an expert team to work on solutions for vehicle, energy, charging and body functions. The power electronics software team develops the diagnostics, security and bootloader functions. Another team is currently being setup for the high-voltage energy management systems for new vehicle platforms.

The rebranding to CARIAD India does not alter the ownership or legal status of Embitel Technologies India Pvt. Ltd. – which continues to be the legal entity. Embitel remains a subsidiary of the diconium group and, thus part of Volkswagen Group Sales IT.

CARIAD® is a trademark of CARIAD SE licensed to Embitel Technologies India Pvt. Ltd.

CARIAD

CARIAD is the automotive software company of the Volkswagen Group. Founded in 2020, CARIAD creates and delivers leading digital technology for brands such as Volkswagen, Audi and Porsche. In software centres in Germany, the USA, China, Estonia and India, more than 6,000 experts work on making the automotive experience safer, more sustainable and more comfortable for everyone. The company’s technology stack includes advanced driver assistance systems, charging technology, a unified infotainment platform, software functions for driving performance, as well as a new digital ecosystem and digital services in and around the vehicle. Iconic cars like the Volkswagen ID. Buzz and ID.7, the Audi Q6 e-tron and the electric Porsche Macan 4 are already equipped with the latest CARIAD technology. With the Volkswagen Group brands, CARIAD aims to transform the car into a software-defined vehicle that relies on software as the basis for most of its functions.

For further information, visit https://cariad.technology.

Embitel

Since its inception in 2006, Embitel Technologies India Pvt. Ltd., has driven digital transformation through advanced technology in the realms of Automotive, Internet of Things, Connected Car and Digital Solutions. Embitel has a proven track record of delivering end-to-end solutions from concept to production for a global client base. The company also provides accelerator solutions that can help customers to reduce overall development time and effort considerably. A Volkswagen Group company, Embitel is a close development partner for CARIAD, the Group’s automotive software company. Embitel also supports CARIAD in enhancing customer experience for digital business and mobility services through seamless e-commerce solutions. Embitel has its corporate office in Bengaluru, with development centres in Ahmedabad, Pune and Coimbatore in India.

Find more information about Embitel at www.embitel.com.

View original content:https://www.prnewswire.com/in/news-releases/cutting-edge-automotive-software-in-india-dedicated-business-unit-of-digital-transformation-specialist-embitel-now-operates-as-cariad-india-302338845.html

Technology

From Local Innovator to Global Player: XData Group’s 2024 Milestones

Published

2 hours ago

December 24, 2024

TALLINN, Estonia, Dec. 24, 2024 /PRNewswire/ — XData Group, a B2B software development firm and a rising fintech innovator based in Tallinn, Estonia, has celebrated a year of exceptional achievements in 2024. Compared to the previous year, the company has doubled its revenue, jumping from €3.3M to €7.8M, while the net profit is expected to be in the €3-3.5 million range. This is a remarkable leap for a growing business, cementing XData’s position as a prominent rising player in the B2B software development space.

The past year has been transformative for XData Group: despite facing challenges in attracting top talent, the company successfully grew its team from 27 to 79 employees, nearly tripling in size. This expansion reflects XData’s ability to draw skilled professionals motivated by a shared vision of reshaping the banking industry through cutting-edge technology.

A significant milestone of 2024 was the release of the company’s flagship banking suite, designed to enhance user experience and operational efficiency in online banking.

Additionally, XData Group expanded its global presence by opening new offices in Spain and Armenia, two emerging tech hubs that align well with the company’s vision and forward-thinking approach.

The company’s client base has also grown as XData secured partnerships with several European banks and financial institutions in the Middle East, showcasing its growing reputation as a trusted partner.

“We are proud of everything we’ve achieved this year and XData’s growing role in driving the adoption of AI and automation in the banking space. As 2025 draws near, our team is committed to scaling our operations even further, doubling down on our proprietary AI-driven solutions and making sure our clients get the best that XData has to offer,” – stated Roman Eloshvili, CEO of XData Group.

XData Group has ambitious plans for the upcoming year: among other things, the company aims to achieve €14 million in revenue and expand its team to 120–130 employees. The company will also shift focus from outsourcing projects to enhancing its internal product development, driving innovation in AI-powered solutions for banking and financial services.

As automation and AI reshape the financial landscape, XData Group intends to stand at the forefront of this transformation, empowering its partners to transition seamlessly into a new age of technology, where financial services become more accessible, efficient, and user-centric.

View original content:https://www.prnewswire.com/news-releases/from-local-innovator-to-global-player-xdata-groups-2024-milestones-302338468.html

SOURCE XData Group